Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Conference item |
| اللغة: | English |
| منشور في: |
International Society for Pharmacoeconomics and Outcomes Research
2024
|